ACACA and metabolic dysfunction-associated steatohepatitis: The anti-NASH effect of IMA-1 mainly depends on its direct binding to the ALOX12 pocket near the interactive surface of ACC1, rather than inhibit the activity of ALOX12 lipoxygenase.